This is a preview of subscription content, log in via an institution to check access.
Notes
2012 US dollars
Reference
Lubinga SJ, et al. A Cost-effectiveness Analysis of Antipsychotics for Treatment of Schizophrenia in Uganda. Applied Health Economics and Health Policy : 10 May 2015. Available from: URL: http://doi.org/10.1007/s40258-015-0176-3
Rights and permissions
About this article
Cite this article
Risperidone cost saving for schizophrenia in Uganda. PharmacoEcon Outcomes News 728, 29 (2015). https://doi.org/10.1007/s40274-015-2149-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2149-z